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INTRODUCTION
As it stands, science has not yet come to fully understand the mechanisms
of mammalian reproduction. However, what has become quite evident, as a result
of research, is that certain components of female reproduction are very important.
The production of female germ cells, known as oocytes in Mus musculus (mice),
through the formation of a pool of primordial follicles, before birth, is one such
integral component (Pepling and Spradling, 1998). The pool of primordial
follicles is essential to reproduction in that it is the complete amount of oocytes
that a female will have available for fertilization for the rest of her life. Thus, it is
important to understand how primordial follicles are assembled and what intrinsic
and extrinsic influences affect their formation. Developing a better understanding
of the formation of these follicles gives scientists further insight into female
sexual maturation and the problems that may arise within it.
The importance of the primordial follicle is also evident as it is the first
step in the ovarian cycle. This cycle is a process involving the enlargement and
maturation of a group of follicles until they are ready to be ovulated (Dean and
Epifano, 2002). It begins with a primordial follicle, which is one oocyte
surrounded by a single layer of flattened granulosa cells that support its growth.
The follicle continues to develop until it becomes a primary follicle. Primary
follicles are denoted by a larger oocyte encased in an increased number of
granulosa cells that have become more cuboidal in shape. The primary follicle
then matures into the secondary follicle. Likewise, the secondary follicle is much
larger than its precursor, but is now surrounded by more than one layer of
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granulosa cells. The oocyte is then surrounded by an extra-cellular matrix called
the zona pellucida that contains proteins that will later allow penetration of sperm.
The granulosa cells then become surrounded by a layer of stromal-like theca cells
that differentiate into the theca externa and interna. A network of capillaries
becomes embedded between these two layers. Few oocytes survive beyond this
point in the cycle. Most oocytes become atretic and die, due to either oocyte or
granulosa cell apoptosis (Hsu and Hsueh 2000). The survivors continue to grow
into tertiary follicles, also known as antral or Graafian follicles. These preovulatory follicles contain a fluid-filled space called an antrum containing
proteins, hormones and other molecules that support the follicle’s continued
growth. This follicle continues to mature until expelled from the ovary as an egg
during ovulation, to possibly be fertilized. The remains of the follicle become the
corpus luteum, which secretes hormones that support pregnancy, but if the egg is
not fertilized within 14 days this turns into the corpus albicans.
The pool of primordial follicles is formed from the oocyte precursor cells
called primordial germ cells (Figure 1). Initially, within the developing mouse
embryo, primordial germ cells migrate to the gonads. By approximately 10.5
days post coitum (dpc) the primordial germ cells have arrived at the gonad,
divided mitotically, and between 10.5 dpc and 13.5 dpc clusters of cells called
germ line cysts form. The oocytes in these cysts are connected via intercellular
bridges that formed as a result of incomplete cytokinesis (Pepling and Spradling
1998). The germ cells enter meiosis at 13.5 dpc and are now considered oocytes.
The oocyte cysts persist until birth. Following birth, these clusters begin to break
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apart in a process coined cyst breakdown (Pepling and Spradling 2001). After the
disassembly of the cysts, individual oocytes eventually become primordial
follicles.
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Figure 1. Timeline of Germ Cell development in Mice (adapted from Pepling,
Spradling, 2001). Yellow cells are oocytes and the red cells are granulosa cells.
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Although the process of cyst breakdown is not yet fully understood, it is
clear that apoptosis, or programmed cell death occurs simultaneously and may be
integral to mammalian reproduction (Pepling and Spradling, 2001). As a result of
germ cell death, approximately two thirds of the oocytes present before birth do
not survive (Pepling and Spradling 2001). According to the model of cyst
breakdown, dying cells disrupt the intercellular bridges (Figure 2). These breaks
diminish the size of the cyst until only a few oocytes remain. It is not known why
these cells die or which cells will undergo apoptosis. However, it has been
postulated that the cells that die serve as nurse cells for the oocytes that survive.
Nurse cells are cells that provide nutrients to the developing oocyte (MahajanMiklos and Cooley, 1994). For example, the Drosophila ovary contains 16-cell
cysts, only one cell in each cyst becomes an oocyte and the other 15 become nurse
cells. These cysts are formed from stem cells that create cystoblasts that divide
exactly four times mitotically and form interconnected cellular bridges by
incomplete cytokenesis. Within these cysts, the nurse cells eventually die by
apoptosis. Overall, it seems apparent that for the primordial follicle formation in
mice requires cyst breakdown and simultaneous apoptosis is imperative.

Figure 2. Model of Cyst Breakdown (Pepling and Spradling, 2001). The
breakdown of an 8 cell cyst. The green cells are apoptotic (dying) and their
death result in the disassembly of the cyst. The process ends in the formation
of single oocytes that will later become surrounded by granulosa cells to
become primordial follicles.
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Cell death and follicular development have been found to be regulated by
steroid hormones such as estrogen (Manglesford et al., 1995, Findlay 1993).
Estrogen is of particular interest in this case because of its extensive impact on
female sexual development. This hormone is known to have an effect on female
sex determination, reproduction, and pregnancy (Kos et al., 2002). Thus, it would
not seem improbable for it to also have a role in cyst breakdown and the
subsequent maintenance of follicular maturation.
Estrogen is a steroid hormone. Though it is most active in females, it is
also known to play critical roles in male sexual development. It is also active in
other bodily functions, such as bone metabolism, and cardiovascular and neuronal
activity (Kos et al., 2002). The hormone is produced by the ovaries, adrenal
glands, and testes. There are three major forms of estrogen active in females
called estradiol, estrone, and estriol. Within the ovary, estrogen production is
initiated by developing follicles and the secretion of follicle stimulating hormone
(FSH) and luteinizing hormone (LH). The process begins with the formation of
androstenedione from cholesterol in the theca cells, which are cells that line the
outside of the granulosa cells. From here this precursor hormone is transported to
the granulosa cell where it is later converted to some form of estrogen, either
estradiol or estrone, via the enzyme aromatase (Kato et al., 1995).
The estrogen hormone signals cells through receptor-mediated pathways.
Research has shown that aberrations in this signaling during development can
lead to multiple and long-term abnormalities in the reproductive system (Jefferson
et al., 2002). Estrogen first maneuvers through the cell membranes, probably by
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diffusion, and comes into contact with an estrogen receptor in the nucleus of the
cell (Figure 3). Estrogen has two receptors, estrogen receptor alpha (ERα) and
estrogen receptor beta (ERβ) (Krege et al., 1998). These receptors are part of the
steroid nuclear receptor superfamily. ERα and ERβ are classified as liganddependent transcription factors whose ligands are either estrogen or estrogen-like
compounds (Mathews and Gustafsson, 2003). These receptors are known to
homodimerize once activated. Once estrogen binds to these receptors, the ligandreceptor complex interacts with a special portion of the DNA present in target
genes called an estrogen response element (ERE). After recruiting co-regulators
and other transcription factors, the target genes are then activated, producing
proteins that go on to elicit pleiotropic effects within the organism.
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Figure 3. Estrogen Signaling Pathway. Estrogen binds to the receptor protein.
The receptor protein then homodimerizes and bind to estrogen response
elements
target
ERαonand
ERβgenes.
are both important for estrogen signaling. Initially,
scientists believed that estrogen signaling was only carried out through ERα, but

7
the discovery of ERβ and the divergence of the two receptors’ expression patterns
implies that they may affect reproductive development quite differently (Jefferson
et al., 2002). ERα is expressed in many parts of the body including the liver,
kidney, heart, and ovary (Matthews and Gustafsson, 2003). Within the adult
ovary ERα is expressed in the theca and interstitial cells (Couse et al., 1999).
However, its expression in the neonatal ovary is unknown. ERβ is mainly
expressed in the ovary, prostate, epididymis, lung, and hypothalamus (Krege et
al., 1998). ERβ is expressed in the granulosa cells of the ovary and has been
detected in neonatal ovaries by RNase protection (Jefferson et al., 2000). Though
ERα is slightly bigger than ERβ, they both have six protein domains (A-F) and
share similar protein domain composition (Figure 4). In both receptors, a ligandindependent transactivation function called AF-1 is present in the A/B domain of
the N-terminus (Hewitt and Korach, 2002). AF-1 along with AF-2, a C-terminal
ligand-dependent activation function found in the E domain, assists with estrogenmediated transcription and cell- and promoter-specificity (Mattews and
Gustafsson, 2003). Domain C is highly conserved; it is responsible for specific
binding to estrogen response elements on the DNA and for receptor dimerization.
The ligand binds to the receptor protein at the E domain, which is less conserved
and partially responsible for dimerization (Dupont and Krust, 2000).
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Figure 4. ERα and ERβ Functional Protein Domain Composition (adapted
from Klinge, 2000). The amino acid length is indicated at the beginning
and end of each domain. Domains C and E are the most homologous (97%
and 55% respectively).
Mutations within both the ERα and ERβ receptors can lead to severe
dysfunction in the adult mouse ovary. Each receptor has been knocked out by
insertion of the neomycin gene into important coding exons (Kos et. al., 2002).
Adult female ERβ knock out (ERβKO or ERβ-/-) mice display smaller litters as a
result of reduced fertility. In these knockout mice there was a decreased number
or absence of corpora lutea, though the ovaries looked fairly normal with normal
antral follicles (Dupont and Krust, 2000).
In adult female ERα-/- mice the phenotypic abnormalities are more severe.
These mice display abnormalities in the reproductive tract, gonads, skeletal and
cardiovascular systems. ERα-/- females have normal follicles until the antral
stage. However, adults later lack corpora lutea and have cystic and hemorrhagic
follicles (Emmen et. al., 2007). Many follicles are atretic. ERα-/- mice do not
ovulate and are thus sterile. There is also an increase in the amount of LH
circulating in ERα-/- females (Rosenfeld et al., 2000). Increased amounts of
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hormones can alter follicle development. Even after being treated with exogenous
gonadotropins, the anovulation phenotype could not be reversed in adult mice
(Couse and Korach, 1999). This suggests that the hormonal imbalance, coupled
with the defective ERα receptor has irreversible and more severe effects on the
adult ovary than ERβ-/-.
Although research on both receptors has yielded important information,
further inquiry into ERα is still necessary when it comes to neonatal mice. In a
study done using neonatal mouse ovaries grown in organ culture, estradiol
treatment inhibited cyst breakdown and primordial follicle formation, but did not
influence oocyte survival (Chen et. al., 2007). In addition, ERα and ERβ receptor
specific agonists cause delays in cyst breakdown (Chen and Pepling, in
preparation). In adult mice, immunohistochemistry has revealed that ERα is
expressed in the interstitial and theca cells of rats, mice, cows, and humans
(Couse et. al., 1999). ERα has also been detected in the human ovary (Couse and
Korach, 1999). However, it is not known where or if ERα is present in the
neonatal mouse ovary. The focus of my research is thus to explore the expression
of ERα in neonatal mice. This study has two goals: 1) determining where ERα is
normally expressed in neonatal ovaries; and 2) discovering what happens to
oocyte development when ERα protein expression is disrupted by examining mice
for defects in primordial follicle formation, cyst breakdown, and oocyte survival.
The results of this research will add substance to what is already known about
estrogen signaling and possibly shed some light on sterility in mice that may be
applied to humans in later studies.
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MATERIALS AND METHODS

Animals
The mouse strain lacking ERα used in this study was obtained from
Jackson Laboratories. In this strain, homologous recombination had been used to
insert a neomycin resistance gene into exon 2 of the ERα gene, disrupting its
function (Lubahn et al., 1993). The mice are maintained as ERα+/- heterozygotes.
To obtain neonatal mice for analysis, matings were set up between two
heterozygous ERα+/- mice. For four days following mating, mice were checked for
vaginal plugs, which would indicate pregnancy. On the day that a female displays
a plug she is isolated and the day is denoted as 0.5 days post coitum (dpc). Birth
usually occurs at 19.5 dpc. This day is then denoted post natal day 1 (PND1).
Neonatal ovaries were harvested from PND1, PND4 and PND7 offspring.
Ovaries were also collected from the CD-1 strain of mice (obtained from Charles
River Laboratories) at various ages for Western blotting and
immunocytochemistry using an antibody against the ERα protein.

Purification of DNA from Mouse Tails
Each mouse was given a metal numerical tag. A piece of tail was then
collected and placed in a centrifuge tube marked with the mouse’s identification
number. The DNA was isolated from tissue via the DNAeasy kit (QIAGEN).
180 microliters (µl) of Buffer AL and 20 µl of the enzyme proteinase K were then
pipetted into each tube. This solution was placed in a 55˚C water bath for at least
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six hours and then vortexed. A one to one mixture of Buffer ATL and 100%
ethanol was prepared. 400 µl of the mixture was added to each sample and then
vortexed. The samples were then transferred into spin columns with collection
tubes attached, to which 500 µl of AW1 buffer plus ethanol was added. The tubes
were centrifuged at 8,000 rpm for one minute. The collection tubes were
discarded and replaced. Then 500 µl of AW2 buffer plus ethanol was added to
each tube and centrifuged at 14,000 rpm for three minutes. The collection tubes
were discarded and replaced, this time with new centrifuge tubes. To elute the
DNA, 100 µl of AE buffer was added to each of these tubes and centrifuged at
8,000 rpm for one minute. Lastly, the DNA was stored at -20˚C to keep it from
degrading.

Polymerase Chain Reaction (PCR)
PCR amplification was used to determine the genotypes of offspring
obtained from crosses of ERα+/- mice. To do this two reactions were used; an A
reaction to amplify the wildtype allele and a B reaction to amplify the mutant
allele. The A reaction mixture consisted of 4.5 µl, 1 µl of 2/FOR primer, 2.5 µl of
2/REVII primer and, 7 µl of Red Taq (Sigma) polymerase. The B reaction
mixture consists of 6 µl of distilled water, 4 µl of 1.25 mM dNTP mixture (1.25
mM of each of dATP, dTTP, dCTP, and dGTP), 2.5 µl of 10X Buffer A, 1 µl
each of primers 13 and 14, and 0.5 µl of Taq polymerase (Fisher). The sequences
of the primers are as follows:
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Primer 2/FOR: 5’-CTGTGTTCAACTACCCCGAGG
Primer 2/REV II: 5’-GGCGCGGGTACCTGTAGAA
Primer 13: 5' CTT GGG TGG AGA GGC TAT TC-3'
Primer 14: 5'AGG TGA GAT GAC AGG AGA TC-3'
P1

P2

EXON 2

EXON 3

2

EXON 3

2

NEO

P1
2

P3

P4
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2
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Figure 5. Primers 1 and 2 anneal to Exon 2 of the ERα gene. A neomycin insertion
is placed into Exon 2 to create the mutant allele (Jackson Laboratories) and primers
3 and 4 amplify the insert.

In the A reaction, primers 2 FOR and 2 REV II amplify a 327 base pair
DNA fragment from the wildtype allele. In the B reaction, primers 13 and 14
amplify a 290 base pair DNA fragment from the targeted allele, amplifying the
neomycin insertion. Using wildtype DNA, only the 327 base pair fragment is
amplified. Using heterozygous (ERα+/-) mice, both the 327 and 290 base pair
fragments are amplified. Using a (ERα-/-) mouse only the 290 base pair fragment
is amplified.
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The total volume in each reaction tube was 15µl. Both tubes were then
placed in the thermocycler on the following ERα programs:
A Reaction:
Stage: 1

Step: 1

2 minutes at 95˚C

Stage: 2

Step: 1

45 seconds at 54˚C

Step: 2

45 seconds at 72˚C

Step: 3

45 seconds at 72˚C

(Stage 2 repeated for 35 cycles)
Stage: 3

Step: 1

7 minutes at 72˚C

(Hold at 4˚C)

B Reaction:
Stage: 1

Step: 1

3 minutes at 95˚C

Stage: 2

Step: 1

30 seconds at 94˚C

Step: 2

1 minute at 64˚C

Step: 3

90 seconds at 72˚C

(Stage 2 repeated for 35 cycles)
Stage: 3

Step: 1

2 minutes at 72˚C

(Hold at 10˚C)

Gel Electrophoresis
Gel electrophoresis was used to determine the size of each PCR product.
To do this, a 2% agarose gel was prepared. To make the gel, 50 ml of 1X TBE
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buffer and 1 gram of agarose were placed into a 125 ml Erlenmeyer flask and
microwaved for 2 minutes. The flask was mixed every 40s so the agarose would
dissolve properly. 2.5 µl of 10 mg/ml ethidium bromide was added to the hot
mixture and swirled for even distribution. The gel was then poured into a gel
tray, equipped with a comb to create individual wells. The gel was then left to
cool for 10-15 minutes. After the gel had solidified, the gel tray was placed into a
gel box and 1X TBE buffer was poured over it until the gel was completely
submerged. The comb was removed. A mixture of 2 µl of 6X loading dye and 10
µl of each PCR product was loaded into each well. 2 µl of 6X loading dye, 5 µl
of 100 bp marker, and 5 µl of 1X TBE buffer were loaded into a well to serve as a
base pair marker, for band size reference. The gel box was then covered and run
at approximately 100 volts for one hour. Kodak Image Station software and UV
detection were then used to take an image of the gel and to analyze the
amplification products.

Dissection
Neonatal ovaries were harvested from both CD1 and ERα mice at PND1,
PND4, and PND7. The ovaries were harvested in 1X phosphate buffered saline
(PBS) using a dissecting microscope. For analysis of ERα mice, a portion of the
tail of each mouse was also collected and placed in a separate tube to be
genotyped.
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Whole Mount Antibody Staining of Neonatal Ovaries
For analysis of ERα mutant mice, ovaries were dissected and placed into
tubes containing 600 µl of fixative, which consisted of 400 µl of 1XPBS and 200
µl of 16% formaldehyde (Ted Pella Inc.), for a final concentration of about 5.3%
formaldehyde. Each of these tubes was labeled according to genotype: wildtype
(ERα+/+), heterozygous mutant (ERα+/-), and homozygous mutant (ERα-/-). Each
tube was then nutated overnight at 4˚C. The ovaries were quickly washed two
times in 1 ml of PT and then a third time in 1 ml (PBS/Triton) PT for at least 30
minutes at room temperature. The ovaries were incubated in PT + 5% bovine
serum albumin (BSA) for 30- 60 minutes on a room temperature nutator. The
ovaries were then incubated with 2.5 µl of primary antibody against the oocyte
marker Stat3 (C20) (Santa Cruz Biotechnology), in 500 µl of PT + 5% BSA
overnight at 4˚C on a nutator (Murphy et al., 2005). They were washed in 1 ml
PT + 1% BSA for 30 minutes at room temperature. Then the ovaries were
incubated in 10 µl of 10 mg/mL RNase A in 1 ml PT +1% BSA for 30 minutes at
room temperature. The ovaries were incubated in 10 µl of 5 µg/ml propidium
iodide in 1 ml of PT + 1% BSA for 20 minutes at room temperature. Propidium
iodide was used as a nuclear marker. At this point each tube was wrapped in
aluminum foil to preserve fluorescence. The ovaries were washed in 1 ml PT
+1% BSA for 30 minutes at room temperature.
The secondary antibody anti-rabbit Alexa 488 (Molecular Probes) was
prepared a day in advance. It was first pre-absorbed by making a 1:200 dilution of
2.5 µl of antibody in 500 µl of PT + 5% BSA and a small amount of embryo
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powder. Embryo powder is a dried mixture of homogenized mouse embryos at
ages 12.5-14.5 dpc. This mixture was then wrapped in aluminum foil and placed
on a 4˚C nutator overnight. The ovaries were then incubated in this pre-absorbed
secondary antibody for 2-4 hours on a room temperature nutator. Next, the
ovaries were washed three times in 1 ml of PT + 1% BSA for 30 minutes each
time on the nutator at room temperature. They were washed once quickly in 1X
PBS. The PBS was then removed, 100 µl of Vectashield (Vector Laboratories)
was added to each tube and incubated for 15 minutes. The ovaries were then
mounted on a slide, with a cover slip and stored at -20˚C.
Antibody staining of neonatal CD1 mice at PND1, PND4, and PND7 was
also done to determine the localization and expression of the ERα protein. The
anti-ERα MC-20 (Santa Cruz Biotechnology) antibody was used as a primary
antibody at 1:100 dilution in this portion of the study. The same Alexa Flour®
488 Goat Anti-rabbit IgG (H+L) (Molecular Probes) described above was used as
a secondary antibody at a 1:200 dilution.

Confocal Microscopy
The collected and stained PND1, PND 4, and PND7 ovaries were
observed via indirect immunofluorescence with the Zeiss Pascal confocal
microscope. The images obtained were used to analyze cyst breakdown, follicle
development and oocyte number. PND7 ERα+/+ images were obtained from the
work of a previous undergraduate in our lab. Eight optical sections were taken per
ovary. Images were obtained from four optical planes at sites at least 5 µm apart
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(8 sections in all). Oocyte number was determined by adding the total number of
oocytes in each optical section. Cyst breakdown was assessed by counting the
number of single oocytes and comparing that the number to the number of
oocytes still in cysts. For this, a stack of ten slices was taken for each of the eight
sections to determine if oocytes were connected in cysts outside of the plane of
focus. Each stack consisted of five images above and below the section being
examined; each image was 1 µm apart from the next. Follicle development was
determined by counting how many oocytes were at each stage of development in
each of the optical sections. If there were no oocytes or follicles in a sample it
was not counted in the average. Oocytes were considered unassembled if
granulosa cells did not completely surround the oocyte. Single oocytes,
completely surrounded by granulosa cells, were classified as primordial, primary,
or secondary. Primordial oocytes were surrounded by a single layer of flattened
granulosa cells. Primary oocytes were surrounded by one layer of granulosa cells
that are cuboidal in shape. Secondary oocytes, considerably larger, were
surrounded by more than one layer of cuboidal granulosa cells.
One-way ANOVA was conducted to look at differences between wildtype
and mutant ovaries for oocyte number, cyst breakdown, and follicle development.
PROC GUM of SAS 9.1 (SAS Institute Inc., Cary, NC) was used to calculate the
least square means and test specific hypotheses for effects. A p value < 0.05 was
considered significant.

Western Blotting
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Western Blotting was utilized to determine if the ERα protein was
expressed in different tissue samples. Ovaries at PND1, PND4, PND7, PND42,
and PND 108 were dissected in 1X PBS and immediately stored on ice. Ovary
extracts were made by homogenizing the ovaries in 10 µl of 1X sample buffer per
ovary. 1X sample buffer is a mixture of 500 µl of 2X sample buffer, 100 µl of
10X stock of protein inhibitor, and 400 µl of distilled water. 2X sample buffer
consists of 4 ml of 10% SDS, 2 ml of glycerol, 1ml of 0.1% bromophenol blue,
2.5 ml of 0.5 M tris (pH 6.8), and 0.5 ml of 2-mercaptoethanol. The proteinase
inhibitor stock was made by dissolving one tablet of mini complete protease
inhibitor (Roche Diagnostics) into 1 ml of distilled water. 20 µl of each ovary
extract is placed into a boil-proof tube and 2 µl of 2-mercaptoethanol was then
added to each. 20 µl of MCF-7 whole cell lysate (Santa Cruz) was used as a
positive control. MCF-7 cells are taken from human breast adenocarcinoma cell
lines and are positive for estrogen receptors (Mairesse et al. 1980). The tubes
were then boiled for three minutes, cooled on ice, and then centrifuged at 6,000
rpm for 1 minute.
A 4-20% polyacrylamide gel was placed in a western blot gel box that was
approximately one-third full of with 1X SDS Running buffer. The running buffer
is made from 100 ml of a 10X stock plus distilled water to bring volume to 1 liter.
The 10X Running Buffer contains 29g of Tris base, 144 g of glycine, 10 g of
SDS, dissolved in 1 liter of distilled water. 20µl of each ovary extract sample was
loaded into a well after the wells had been cleaned. 10 µl of Precision Plus
Standard Protein marker (Bio-Rad) plus 10 µl of 2X sample buffer was added into
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the first well as a reference for band size. Gel electrophoresis was performed at
100 volts for approximately 1 hour.
Protein was transferred to a Polyvilnidene fluoride (PVDF) membrane
(Millipore) as follows. A 6 x 8 cm piece of PVDF membrane was soaked in
methanol for 1 minute and then washed in distilled water for 5 minutes. The
PVDF membrane and gel were then soaked in Transfer buffer for 5 minutes (in
separate trays). Simultaneously, two pieces of filter paper cut to the size of the
gel and two fiber pads were also soaked in Transfer buffer for 5 minutes. The
Transfer buffer contains 3.0 g of Tris base, 14.4 g of glycine, and 200 ml of
methanol in distilled water brought to a total volume of 1 liter and stored in a dark
bottle at 4˚C. All of the materials were placed in a transfer cassette, dark side (of
the transfer cassette) down, in the following order: fiber pad, filter paper, gel,
membrane, filter paper, fiber pad. The transfer cassette was then inserted into the
transfer casket with the black side of the cassette facing the black side of the
casket. A magnetic stir bar was then placed into the transfer unit. The transfer
casket was placed into the transfer unit, with the black side facing a pre-made ice
cube. The transfer unit was filled with Transfer buffer. The unit was placed at
4˚C fridge and the transfer was performed at 100 volts for one hour. The gel was
then stained with Coomassie Blue for 30 minutes to visualize whether the protein
had run and for preservation. The gel was then washed with destain solution
overnight. The destain solution consisted of 450 ml of distilled water, 450 ml of
methanol, and 90 ml of acetic acid. The gel was dried on a glass frame and gel
wrap. The membrane was put into Blocking buffer in a tray on a shaker for 30
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minutes at room temperature, the buffer was then changed and the membrane was
stored at 4˚C overnight. Blocking buffer contains 100 ml of 10X PBS 50 g of 5%
nonfat dry milk, and 0.5 ml of 0.05% Tween 20 in distilled water brought to a
volume of 1 liter.
The membrane was then incubated in primary antibody diluted in
Blocking buffer and placed on a nutator at room temperature for one hour. ERα
MC-20 (Santa Cruz) was used as the primary antibody at a concentration of
1:500. The membrane was washed in Blocking buffer for three 10 minute
intervals on a shaker at room temperature. It was then incubated in secondary
antibody diluted in blocking buffer for one hour on a room temperature nutator.
The secondary antibody used was goat anti-rabbit conjugated to horseradish
peroxidase (HRP) (Jackson Immunolabs) in dilutions ranging from 1:10,000 to
1:15,000.
Following antibody treatment the membrane was then placed in Wash
buffer for 10 minutes on a shaker at room temperature. The Wash buffer contains
0.05% Tween in 1X PBS. The membrane was washed in 1X PBS, placed in a 1:1
mixture of detection and enhancer solutions (Pierce), 5 ml per membrane, for 5
minutes on the shaker, and then rinsed in distilled water. A plastic pouch cut
slightly larger than the PVDF membrane was then prepared and the membrane
placed inside. The plastic pouch was taped to a cardboard mount and exposed to
autoradiography film to detect the ERα protein.
The PVDF membrane was reprobed with the antibody against
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (EnCor Biotechnology
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Inc.) as a loading control. The membrane was first rinsed in 1X PBS. It was then
placed in a Blocking buffer for one hour on shaker at room temperature. The
same detection procedure was then followed using GAPDH at 1:500 as a primary
antibody and anti-mouse-HRP (Santa Cruz) at 1:10,000 as the secondary
antibody.
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RESULTS

Expression of ERα in Neonatal Mouse Ovaries
Western blot analyses were carried out to detect the ERα protein in ovaries
at several different ages (Figure 6). Anti-ERα antibody, MC-20, was used at a
1:500 dilution and the goat anti-rabbit was used as at 1:10,000 dilution. ERα is
known to have at least three splice variants corresponding to proteins of 66, 55,
and 46 kDa (Pendaries et al., 2002). MCF7 cell lysate, containing a human ERα
protein taken from human breast adenocarcinoma lines was used as a positive
control. A band at 46 kDa corresponding to ERα protein was detected in the
positive control. Bands at 66 kDa and 55 kDa were detected for PND1, 4, and 7
wildtype mice. PND 108 displayed bands at 66 kDa, 46 kDa, and 30 kDa. The
ERα MC-20 antibody is directed toward the C-terminal portion and will detect all
three ERα isoforms (66 kDa, 55 kDa, and 46 kDa). The blot was reprobed with
GAPDH as a loading control.
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A.

B.

Figure 6. Western Blot Analysis of ERα Protein. A. MCF7 whole cell
lysate purified from human breast adenocarcinoma lines was used as a
positive control. Tissue extracts from wildtype CD-1 mice at PND1,
PND4, PND7, PND108 were probed with ERα MC-20 antibody. B. Blots
were reprobed with GAPDH.
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An additional Western blot was run with PND1, PND4, PND7, and
PND42 ovary extracts from wildtype CD-1 mice. ERα MC-20 was kept at the
same concentration as the previous blot, but the goat anti-rabbit secondary
concentration was adjusted to 1:15,000 in an effort to reduce background. Three
PND42 extracts were used to detect the difference in expression of the ERα
protein in ERα+/+, ERα+/-, and ERα-/- mice. Results from the Western blot indicate
66 kDa and 55 kDa isoforms are present at PND1 and PND4 (Figure 7). The 66
kDa isoform was detected at PND7. All three of the PND42 extracts contain the
66 kDa isoform; the level is highest in PND42 ERα+/+extracts and lowest in

PND 42 ER α +/+

PND7

PND4

PND1

PND 42 ER α -/-

A.

PND 42 ER α +/-

PND42 ERα-/- extracts (Figure 7).

B.

Figure 7. Western Blot Analysis of ERα Protein. A. PND1, PND4, PND7,
and PND42 ERα wildtype (+/+), heterozygote (+/-), and homozygous mutant
(-/-) were probed with ERα MC-20 antibody. B. Blots were reprobed with
GAPDH as a loading control.
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Whole mount indirect immunofluorescence was carried out to determine
the localization of the ERα protein in wildtype CD1 strain neonatal ovaries. The
anti-ERα MC-20 antibody was used to detect ERα in CD-1 mouse ovaries at
PND1, PND4, and PND7. Ovaries were also labeled with propidium iodide to
visualize DNA (nuclei). The ERα protein is not detected in oocytes or somatic
cells at PND1, PND4 or PND7 (Figure 8).

A.

B.

C.

Figure 8. Detection of ERα Protein Using MC-20 Antibody.
A. In staining of PND1 ovaries, ERα exhibits non-specific
staining. B. PND4 exhibits non-specific staining. C. PND7
exhibits non-specific staining.
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Cyst Breakdown in ERα Mutant Mice
Estrogen treatment has been implicated in aberrant cyst breakdown in
neonatal mice, suggesting that estrogen signaling has a role in cyst breakdown
(Chen et al., 2007). Neonatal mice treated with genistein, an estrogen-like
compound found in soybeans, exhibit multiple oocyte follicles (MOFs) in ovaries
as adults (Jefferson et al., 2002). ERα knockout mice treated with genistein
exhibit MOFs, while ERβ knockout mice do not (Jefferson et al., 2002). This
result implies that genistein signals through ERβ. However, both ERα and ERβ
agonists can inhibit cyst breakdown (Chen and Pepling, in preparation). This
implies that ERα as well as ERβ may be involved in cyst breakdown. To
determine the role of ERα in cyst breakdown and oocyte development, ERα+/+,
ERα+/-, and ERα-/- mice were examined at PND1, PND4, and PND7. Cyst
breakdown was determined by comparing the number of oocytes in cysts to the
number of single oocytes. The average percentage of single oocytes increased
during the seven days of development as expected in all genotypes, indicating that
the process of cyst breakdown was occurring (Figure 9). The single oocyte
percentage was elevated in ERα+/-, and ERα-/- mice as compared to ERα+/+ at
PND1, however, it was determined that this difference was not statistically
significant (Figures 10).

There is no significant difference in cyst breakdown

across the genotypes at PND4 (Figure 11). However, there is a slight decrease in
single oocyte percentage in ERα-/- ovaries, but this is not statistically significant.
Thus, cyst breakdown occurred similarly across genotypes at PND4. At PND7,
ERα+/- and ERα-/- ovaries had an increased percentage of single oocytes and this
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difference was statistically significant (Figure 12). Thus, cyst breakdown appears
to be accelerated at PND7.
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Figure 9. Summary of Cyst Breakdown at PND1, PND4, and PND7 in ERα+/+,
ERα+/-, and ERα-/- mice. A rise in single oocyte percentage is indicative of cyst
breakdown from PND1 to PND7. * indicates a statistically significant difference
between the genotypes with p<0.05 considered statistically significant. N= 7-40
sections in 1-5 ovaries.
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PND1 Cyst Breakdown in ER Alpha Mutants
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Figure 10. Cyst Breakdown at PND1 in ERα+/+, ERα+/-, and ERα-/- mice.
There is more cyst breakdown in ERα+/- and ERα-/- at PND1 as compared
with to ERα+/+, but this is not statistically significant. N= 72 sections in
9 ovaries (3 per genotype).
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Figure 11. Cyst Breakdown at PND4 in ERα+/+, ERα+/-, and ERα-/- mice.
There is no statistical significance difference between cyst breakdown
between these three genotypes at PND4. N= 12-40 sections in 2-5
ovaries
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PND7 Cyst Breakdown in ER Alpha Mutants
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Figure 12. Cyst Breakdown at PND7 in ERα+/+, ERα+/-, and ERα-/- mice. Cyst
breakdown is elevated in PND7 in ERα+/- and ERα-/- resulting in a higher single
oocyte percentage. Differences between genotypes were statistically significant.
* indicates statistical significance where p<0.05. N= 7-40 sections in 1-5 ovaries.

Total Oocyte Numbers in ERα Mutants
The total number of oocytes per confocal section was determined for
ERα+/+, ERα+/-, and ERα-/- at PND1, PND4, and PND7 to establish whether ERα
has a role in oocyte survival. At PND1, there was higher average total oocyte
number in all three genotypes, than at PND4 and PND7 (Figure 13). PND4 and
PND7 had lower average total oocyte numbers, showing a decline of oocyte
number during the seven days of development, which normally occurs at this
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time. Although there were variations in oocyte number at PND1, PND4, and
PND7, no differences were determined to be statistically significant.
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Figure 13. Total Number of Oocytes at PND1, PND4, and PND7 in ERα+/+, ERα+/-,
and ERα-/- mice. Differences between genotypes were not statistically significant. N=
7-40 sections in 1-5 ovaries.
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Follicle Development in ERα Mutants
To determine if ERα had a significant role in follicle development,
oocytes collected at PND1, PND4, and PND7 were assessed using confocal
microscopy. For each confocal section, oocytes were classified as primordial,
primary, or secondary follicles (Figure 14). At PND1, most oocytes were
unassembled, and the oocytes that were enclosed by granulosa cells were in
primordial follicles. There was no significant difference in development across
all stages and genotypes at PND1 (Figure 15). Likewise, there was no significant
difference in development across all stages and genotypes at PND7 (Figure 17).
In contrast, ERα+/- and ERα-/- primordial follicle development was
different from ERα+/+ at PND4 (Figure 16). ERα+/- has a slightly lower number of
oocytes in primordial follicles than did wildtype, but this is not statistically
significant. However, ERα-/- had considerably more oocytes in primordial follicles
than did the other genotypes. Also, oocytes from ERα-/- mice did not develop past
the primordial follicle stage, suggesting that they arrested in this phase of
development and this difference is statistically significant. Primary and secondary
follicle development at PND1 and PND7 exhibited no significant difference
between the genotypes.
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Figure 14. Stages of Follicle Development. Oocytes with connecting
cytoplasm are classified as unassembled (cysts). Primordial follicles
consist of one oocyte and a single layer of flattened granulosa cells. As
these follicles mature the oocyte increases in volume and its surrounding
layer of granulosa cells become more cuboidal in shape. Granulosa cells
increase in number. At this point, the follicle is considered primary. The
oocyte continues to develop into a secondary follicle, denoted by more
than one layer of granulosa cells.

33

100
90
80
Percent Oocytes

70
60

(+/+)

50

(+/-)
(-/-)

40
30
20
10
0
Primordial

Primary

Secondary

Follicles

Figure 15. Follicle Development at PND1 in ERα+/+, ERα+/-, and ERα-/- mice.
Difference between genotypes was not statistically significant. N= 72 sections in 9
ovaries.
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Figure 16. Follicle Development at PND4 in ERα+/+, ERα+/-, and ERα-/- mice. *
indicates statistically significant difference between the genotypes with p<0.05. N=
12-40 sections in 2-5 ovaries.
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Figure 17. Follicle Development at PND7 in ERα+/+, ERα+/-, and ERα-/- mice.
Differences between the genotypes were not statistically significant. N= 7-40
sections in 1-5 ovaries.
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DISCUSSION

Estrogen signals through receptor-mediated pathways. Disruption of
pathways results in abnormalities in the adult (Jefferson et al., 2002) and neonatal
reproductive systems (Chen et al., 2007). However, it is not known whether ERα
plays an integral role in normal oocyte development or if the occurrence of these
abnormalities in mice may be an indirect effect of a disruption in this receptor.
Thus, the main objectives of this research were to establish whether ERα was
expressed in neonatal ovaries and if so where, and to examine ERα homozygous
mutant mice for defects in neonatal cyst breakdown, oocyte survival and follicle
development at PND1, PND4, and PND7.
The ERα protein was detected in neonatal ovaries using protein Western
blot analyses. The expected size of the “classical” full-length ERα is 66 kDa
(Pendaries et al., 2002). A protein of this size was detected in PND1, PND4,
PND7, and PND108 tissue samples by Western blotting (Figure 6). However,
there were also polypeptides detected at 55kDa and 46kDa in PND1, PND4, and
PND7. ERα is known to have three isoforms, the 55 kDa and 46 kDa isoforms
being ERα mRNA splice variants (Pendaries et al., 2002). They are all detected
by the ERα MC-20 antibody, which explains why these other isoforms were
detected (Pendaries et a., 2002). Likewise, the MCF7 human ERα positive
control exhibited a band at 46 kDa. Therefore, all of the mouse protein extracts
contained ERα, indicating that the protein was in fact expressed at the
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developmental stages assayed. There was also protein detected at approximately
30 kDa at PND108, which may have been due to protein degradation.
A second Western blot was run to determine whether the ERα protein
level was reduced in ERα+/- ovaries and absent from ERα-/- ovaries. Tissue
samples from PND42 (adult) ERα+/+, ERα+/-, and ERα-/- mice were collected and
run on the western with the original tissue samples from PND1, PND4, and PND7
(Figure 7). As was expected, the ERα+/+ tissue sample showed the strongest band
and ERα+/- showed a weaker band. It was initially hypothesized that the ERα
protein would not be detected in the ERα-/- tissue sample due to the fact that the
gene had been knocked out. However, the ERα protein was detected, though very
weakly. This may have occurred because the ERα-/- mouse may not have been a
full knockout and thus may have retained some of its protein activity.
In the second Western blot the concentration of the secondary antibody
goat anti-rabbit was increased from 1:10,000 to 1:15,000. This was done in
efforts to minimize the appearance of background or nonspecific labeling. Based
on the results of the second Western blot, the concentration change did not have
the desired effects because portions of the Western were still blurry. Further
analysis of the ERα protein will have to be carried out to alleviate issues with
concentrations, full ERα knockout protein expression, and to increase overall
understanding of the ERα protein.
ERα localization was also investigated in this study. ERα is expressed by
theca cells in the adult ovary. The ERα protein is detected as early as PND1 by
Western blotting. However, the results of immunocytochemistry only show non-
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specific staining in the PND1, PND4, and PND7 ovary. Due to the confirmed
expression via Western blot, it was assumed that the concentration of the MC-20
antibody needed to be increased to exhibit results that mirror that of the Western
blot analysis, or that the protein is expressed at very low levels.
ERα protein activity was further analyzed in the assessment of oocyte
development using mutants lacking ERα. The total number of oocytes per
confocal section was examined to determine if there were significant differences
in oocyte survival across all three genotypes at each age of development. There
was an overall loss of oocytes across all genotypes, indicating that germ cell loss
is a regulated process that occurs in ERα+/+, ERα+/-, and ERα-/- over the seven
days of development normally (Pepling and Spradling, 2001). However, there
was a significantly lower amount of oocytes in ERα+/- and ERα-/- than there was in
ERα+/+ animals, in all three days of development. This would suggest that
reduction in the level of ERα may accelerate oocyte loss.
Single oocyte percentage was examined to determine if ERα had a role in
cyst breakdown. PND4 and PND7 showed the highest percentages of single
oocytes. This confirms that cyst breakdown did occur and that by PND7 the
majority of oocytes were single. There did not seem to be a significant difference
in single oocyte percentage between the genotypes at PND4. However, there was
an elevated percentage of single oocytes in ERα+/- and ERα-/- relative to ERα+/+
animals at PND1 and PND7. This suggests that at PND1 and PND7 cyst
breakdown is elevated. However, the results at PND4 are not consistent with this
interpretation.
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Past research using estradiol treatment on neonatal mice suggested that
estrogen signaling had a major role in preventing or delaying cyst breakdown
(Chen et al., 2007). Thus it was originally postulated that ERα was necessary for
the maintenance of cysts, and mice lacking this receptor would have accelerated
cyst breakdown. The results presented here are inconclusive. One possible
interpretation is as follows: perhaps ERα activity is important for the maintenance
of cysts at PND1, thus its absence serves to speed up cyst breakdown. It is
possible that by PND4, ERβ compensates for the lack of ERα activity and cyst
breakdown rates begin to normalize, but by PND7 ERβ is no longer able to
compensate and the increase in cyst breakdown returns as a result. Ultimately the
results of this research are not conclusive enough to provide true evidence for
these hypotheses, and further research will need to be done to determine whether
ERα truly plays a role in cyst breakdown.
In the examination of ERα’s role in follicle development, there was no
difference in follicle development across all genotypes at PND1 and PND7. At
PND4 there seemed to be a lower number of primordial follicles in the ERα+/heterozygote than the ERα+/+ wildtype and ERα-/- mutant mice. There is also a
considerably higher percentage of oocytes in primordial follicles in ERα-/- mice
than ERα+/- and ERα+/+ mice. Strikingly, there are no primary or secondary
follicles in ERα-/-. This indicates that there is an inhibition of primordial follicle
development and the follicles can not advance to the primary stage as a result in
ERα-/- at PND4. Again, further research will be needed to support this idea.
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There seemed to be the most noticeable differences in oocyte development
at PND4. However, since these trends were not continuous throughout PND1 and
PND7, it is difficult to derive concrete conclusions. A number of factors may
have contributed to this. Determining the stage of oocyte development was often
an issue when it came to distinguishing a definite stage for oocytes that were
transitioning between phases of follicle development. The creation of a consistent
and universal method of making this determination and counting oocytes
according to it would probably help to alleviate this problem.
Technical difficulties may have played a role in discrepancies in data
collection. An inability to accurately genotype collected ovaries via PCR analysis
delayed the research process, leaving less time to analyze those ovaries initially
collected once the PCR problem was solved. This also left less time to collect
more ovaries for a consistent sample size across genotypes. In particular, it was
difficult to acquire as many homozygous mutant ovaries for analysis as
heterozygous ovaries at PND1 and PND4. It was also difficult to acquire
wildtype ovaries for all three ages. Thus, smaller sample sizes for homozygous
mutant and wildtype ovaries may have contributed to inconclusive results. There
were also technical difficulties with antibody staining, due to a lack of germ cell
staining, it was difficult to distinguish developmental stages. More accurate
results will require the collection of a larger and consistent number of ovaries
from each genotype and developmental stage.
The purpose of this research was to further investigate how cyst
breakdown, cell death, and follicle development are regulated in the neonatal
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ovary. It is known that these processes occur in all mammals, including humans
(Pepling, 2006). It is our hope that research in mice will help us to further
uncover the mechanisms involved in these processes. Since the pool of oocytes
that one will have throughout her entire life is designated at birth, it is our hope
that this research sheds more light on how this pool is established. Likewise,
estrogen has a major role in the development of these germ cells. With the
discovery of how endocrine disruption can have a deleterious effect on
reproductive ability, coupled with the appearance of hormones in just about every
product we ingest, it is imperative that these type of studies be carried out so
scientists have a better understanding of how to combat their possible negative
effects. Thus, further research is necessary to create preventative and corrective
methods for disorders in estrogen signaling and ultimately establishing an
increased understanding of germ cell development as a whole.
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Capstone Summary

Reproductive ability is an issue that has maintained importance in the
world. Thus, as with most issues, scientists are working diligently to study and
form a better understanding of how the reproductive system operates. In females,
this study is mainly based around the capacity to produce viable oocytes or eggs.
In the mouse model system, the production of these eggs begins well before birth,
where precursor cells called primordial germ cells divide a number of times by
mitosis. Mitosis is the process by which cells in the body divide to create
duplicates of themselves. After these primordial germ cells, or egg precursors,
divide they form cysts, or clusters of cells that are still connected because of
incomplete severance after divisions. Eventually, after birth in mice, a number of
cells begin to die via programmed cell death (also known as apoptosis) and these
cysts begin to break down. The end result is what is known as a primordial
follicle, or one oocyte/egg surrounded by a number of flattened supporting cells
called granulosa cells. This step is of extreme importance and interest because the
pool of primordial follicles a female has after birth is all she will have for the rest
of her life. This research has looked into the mechanisms involved in the cyst
breakdown that leads to the formation of this primordial follicle pool, the ability
of oocytes to survive despite programmed cell death, and how follicle
development continues after primordial follicle formation.
It is well-known that estrogen has many roles in sexual development in
females. Therefore, it is not difficult to assume that it may have a role in the
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individual stages of egg development. Estrogen is a steroid hormone. There are
three types of estrogen that circulate in the body called estradiol, estriol, and
estrone. Estradiol is the most prevalent form. Estrogen operates through two types
of protein called estrogen receptors located in the nucleus of a cell. These
receptors are specifically called estrogen receptor alpha (ERα) and estrogen
receptor beta (ERβ). In order for estrogen to carry out its effects, it must first bind
to these receptors. The estrogen-bound receptors then homodimerize, meaning
that two of the same type of receptor (i.e. two ERαs) bind to each other, and then
the homodimer binds to a specific part of the DNA that recognizes this complex
called an estrogen response element (ERE). After binding to the DNA, the
receptor-estrogen complex recruits helpers called co-regulators to transcribe, or
read, the DNA and produce RNA. Ultimately, the RNA is translated into proteins
that will carry out estrogen’s effects throughout the body.
Previous research has shown that estrogen’s mechanism of action can be
disrupted and lead to malfunctions in normal cyst breakdown, egg production, and
development. When neonatal (baby) mice were treated with genistein, an
estrogen-like compound (behaves like estrogen in the cell) found in soy plants,
they developed multiple oocyte follicles (MOFs) in adulthood. Throughout the
female life, eggs go through a number of stages of development where the egg is
encased in supporting cells and called a follicle. Follicle development, prior to
ovulation, normally proceeds from primordial follicle, to primary, and then
secondary follicle, where the shape of the granulosa cells becomes more cuboidal
and their number increases, and the oocyte itself gets larger with each stage.
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MOFs are thought to be the result of incomplete cyst breakdown that leads to
more than one egg per follicle. Another study was done treating neonatal (baby)
mouse ovaries with estradiol (excess estrogen that operates through both
receptors). Researchers found that cyst breakdown was inhibited; the oocytes
remain in cysts instead of separating breaking down into single oocytes in
primordial follicles. All of this tells us that estrogen has a definite effect on cyst
breakdown and since it works through ERα and ERβ, they too have a role in this
process.
Both ERα and ERβ have been shown to be important in the body. Initially,
scientists thought that ERα was the only estrogen receptor, but recent research has
shown that ERβ is also an estrogen receptor. ERβ is found in the ovary,
epididymis, prostate, lung, and hypothalamus. ERα is found throughout the body
in many areas including the ovary. Our research is particularly focused on these
receptors’ effects in the ovary when they are working normally and also on the
consequences of loss of ERα activity. ERβ activity in the ovary is found in the
granulosa cells that surround the oocyte (egg). Research has shown that when this
receptor’s activity is disrupted, meaning that it no longer works or is knocked out
in mice, the mice develop normally, but have smaller litters. However, my
research is focused on the role of ERα. ERα is expressed in other supporting cells
called theca cells, which line the granulosa cells. If the ERα receptor is disrupted,
past research showed that adult mice are infertile, lack corpus lutea (which
secretes hormones that support implantation of the egg into the uterus after
fertilization), and have hemorrhagic (bleeding) and cystic (follicles that fail to
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ovulate) follicles. Although studies tell us a great deal about ERα in adult and
treated neonatal mice ovaries, there has been no research done on the role of ERα
in normal neonatal and the mutant phenotypes of mice lacking working ERα.
As a result of the lack of information on neonatal mice lacking ERα, my
research is focused on the role of ERα in oocyte development in these mice. Since
lacking this receptor is shown to have such severe effects in adult mice, it was my
hope to establish whether these effects could be detected earlier on in
reproductive development. This research attempted to answer two questions: 1) is
ERα expressed (present) in normal neonatal ovaries and if so where; and 2) what
are the effects on cyst breakdown, oocyte number (survival), and follicle
development when ERα is absent.
A number of scientific methods were used to answer these questions. Mice
from a normal strain (no abnormalities in ERα activity) called CD-1 was used to
answer the first question. A technique called Western blot analysis was used to
test whether the ERα protein was present in the neonatal ovary in these mice.
Ovaries were collected from mice at 1, 4, and 7 days after birth (called PND1,
PND4, and PND7 from now on), which is the time when cyst breakdown, cell
apoptosis, and primordial follicle development occurs. To find out if ERα was
localized to the theca cells as it is in adult mice ovaries, were treated with an
antibody against the ERα protein called MC-20 and a secondary antibody
equipped with a fluorescent tag that would label MC-20.
Mice that were purchased as ERα heterozygotes (having one normal copy
and one defective copy) and bred to produce mice with two normal copies of
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ERα, one normal/one defective, and two defective copies were also used to
answer the second question. Ovaries were collected from these mice at PND1,
PND4, and PND7 as well. Polymerase chain reactions (PCRs), which amplify
specific regions of DNA (the ERα gene in this case) were used to detect normal
(working) or mutant (disrupted) copies of the gene. The amplification product was
then used visualized using gel electrophoresis, a technique which uses UV light to
detect fragments of DNA. This method was used to determine the genotype of
each mouse. The genotype is the genetic profile, indicating the presence of genes.
In this case, if a mouse has two normal copies of the ERα gene it is known as ERα
wildtype (normal), if it has one normal and one defective copy it is ERα
heterozygous, if it has two defective copies the mouse is considered ERα mutant.
Once it was known which type of mouse the ovaries came from, a fluorescent
marker was used to label the oocytes/eggs in these ovaries. Pictures were then
taken of the ovaries using a fluorescent microscope called a confocal microscope.
Oocytes in these pictures were counted and analyzed to see if there were
differences in cyst breakdown, oocyte survival, and follicle development in the
wildtype, heterozygote, and mutant ERα mice.
The results of this study were as follows. A technique called Western blot
analysis indicated that ERα was present in neonatal ovaries. However, labeling
ovaries with the fluorescent tag did not show any ERα present, suggesting that the
expression was very low at PND1, PND4, and PND7. By analyzing the pictures
that were taken of the ovaries from the ERα wildtype (normal), ERα
heterozygous, and ERα mutant mice, we were able to see limited differences. Cyst
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breakdown increased over the seven days of development as it should have for all
three genotypes. However, the rate that the cysts were breaking down was faster
in the heterozygous (having partial ERα activity) and mutant (having no ERα
activity) mice, than it was in normal mice (having fully active ERα) at the PND7.
This indicates that ERα may have a role in the normal rate of cyst breakdown.
There was no significant difference in oocyte survival between the different types
of mice in all seven days of development, suggesting that ERα does not have a
role in oocyte survival or programmed cell death. In this study, follicle
development was found to proceed normally in all types of mice at PND1 and
PND7. However, at PND4, the ERα mutant mice were all at the primordial
follicle stage. Normally by this time some oocytes have moved into the primary
and secondary follicle stage. However, this is not the case in the ERα mutants.
This indicates that at PND4, mutant mice were arrested in their development and
could not develop past the primordial follicle stage. Thus, ERα may have a role in
follicle development as well.
Overall, this research is important for a better understanding of how
reproductive development works in the ovary. Many of the conclusions made will
need further research to support them because of small sample sizes (small
numbers of ovaries analyzed) and inconsistent oocyte counting methods.
However, this research does contribute information about the role of ERα, which
was not previously known. Hopefully, this will be able to be used by future
researchers to fully explain how estrogen operates in the body. Ultimately,
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scientists hope to utilize this and other research in the field of reproductive
development to properly diagnose and treat human infertility.

